The consequences of CT, GC, and TV can be serious. Long- term sequelae include pelvic inflammatory disease, ectopic pregnancy, infertility, and pre-term or low birth-weight infants.
More than 1 million STIs are acquired every day. In 2016, WHO estimated 376 million new infections with 1 of 4 STIs: trichomoniasis (156 M), chlamydia (127 M), gonorrhoea (87 M) and syphilis (6.3 M).2
Despite being the most common curable STI worldwide, trichomoniasis is not a reportable disease in Europe, and is often not a requested test.
Hospitals and laboratories are faced with increasing challenges in managing workload and patient needs.
Screening and/or diagnosis of STIs requires an assay capable of accurate detection of infections that are often asymptomatic, while common symptoms can make differentiating these infections difficult.
Labs and clinicians require results they can trust and efficient solutions that help them reduce labour, workload and costs.